Comparison of Biochemical and Hematological Profile in Pulmonary and Extrapulmonary Tuberculosis at Gulab Devi Teaching Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i7.1786Keywords:
Pulmonary Tuberculosis, Extrapulmonary Tuberculosis, Pediatrics, Hematological Profile, Biochemical Markers, Gulab Devi HospitalAbstract
Introduction: Tuberculosis (TB) remains a significant cause of morbidity among children in developing countries. Differentiating between pulmonary TB (PTB) and extrapulmonary TB (EPTB) based on laboratory parameters can aid in timely diagnosis and management. This study aimed to compare the biochemical and hematological profiles of pediatric patients diagnosed with PTB and EPTB at Gulab Devi Teaching Hospital. Methodology: This descriptive case series included 120 pediatric patients under 14 years of age diagnosed with TB over a three-month period. Patients were divided into PTB and EPTB groups. Biochemical and hematological parameters including Hb, RBCs, WBCs, TLC, PLT, ESR, CRP, and differential counts were analyzed. Radiological and clinical features such as TST positivity, chest X-ray findings, lymphadenopathy, cavity lesions, and miliary TB were also compared between groups. Data were analyzed using SPSS v25.0 with p ≤ 0.05 considered statistically significant. Results: Out of 120 patients, 74 (61.7%) had PTB and 46 (38.3%) had EPTB. Mean age was 7.01 ± 4.31 years, with a nearly equal gender distribution. PTB patients had significantly higher TLC (11.49 ± 1.95 vs. 8.30 ± 1.57; p=0.001) and WBC counts (11.10 ± 1.77 vs. 9.86 ± 1.58; p=0.001) compared to EPTB. Other hematological and biochemical parameters showed no significant differences. TST positivity was more frequent in EPTB (95.7% vs. 78.4%; p=0.010). Conclusion: While most biochemical and hematological markers were comparable between PTB and EPTB, significantly higher leukocyte counts in PTB suggest a more pronounced inflammatory response. Radiological findings and TST also differed notably, which can aid in clinical differentiation and early diagnosis.
Downloads
References
Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. The Lancet Respiratory Medicine. 2018;6(4):299-314.
https://doi.org/10.1016/s2213-2600(18)30057-2
Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;1(1):7-12.
https://doi.org/10.1016/j.ijid.2021.02.107
Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751-63.
https://doi.org/10.1159/000512531
Menzies NA, Bellerose M, Testa C, Swartwood NA, Malyuta Y, Cohen T, et al. Impact of effective global tuberculosis control on health and economic outcomes in the United States. Am J Respiratory Critical Care Med. 2020;202(11):1567-75.
https://doi.org/10.1164/rccm.202003-0526oc
Golden MP, Vikram HR. Extrapulmonary tuberculosis: An overview. Am Fam Physician. 2005;72(9):1761-1768.
Natarajan A, Beena PM, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberculosis. 2020;67(3):295-311.
https://doi.org/10.1016/j.ijtb.2020.02.005
Batool Y, Pervaiz G, Arooj A, Fatima S. Hematological manifestations in patients newly diagnosed with pulmonary tuberculosis. Pak J Med Sci. 2022;38(7):1968-72.
https://doi.org/10.12669/pjms.38.7.5911
Singh S, Chegondi M, Chacham S, Kumar P, Goyal JP. Comparison of clinical and laboratory profile of pulmonary and extrapulmonary tuberculosis in children: A single-center experience from India. J Clin Transl Res. 2021;7(4):423-427.
https://doi.org/10.18053/jctres.07.202104.004
Shyama S, Ojha VS, Biswas R, Luv L, Kaur G, Jaiswal Y, et al. Comparison of Biochemical and Hematological Profiles in Patients of Extrapulmonary and Pulmonary Tuberculosis at a Tertiary Care Center. Cureus. 2023;15(3):e35778.
https://doi.org/10.7759/cureus.35778
Aygün D, Cakir E, Okur N, Sigirci A, Tastan Y, Kara A. Evaluation of clinical and laboratory characteristics of children with pulmonary and extrapulmonary tuberculosis. Turk Arch Pediatr. 2020;55(1):32-37.
https://doi.org/10.3390/medicina55080428
Ştefanescu S, Cocoş R, Turcu-Stiolica A, Mahler B, Meca AD, Giura AM, et al. Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania. PLoS One. 2021;16(4):e0249301.
https://doi.org/10.1371/journal.pone.0249301
Kumar NP, Moideen K, Dhakshinraj SD, Banurekha VV, Nair D, Dolla C, et al. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Infect Dis. 2023;56(10):1414-22.
https://doi.org/10.1111/imm.12496
Özkan S, Çakır E, Kocabaş E, Çelebi S, Özkan F. Evaluation of cases of pediatric extrapulmonary tuberculosis: a single center experience. Turk J Med Sci. 2019;49(4):1093-1099.
Dubois MM, Sossen B, Seddon JA, Marx FM, Coussens AK, Thuong NTT, et al. Age-specific Clinical Presentation and Risk Factors for Extrapulmonary Tuberculosis in Children: A Systematic Review and Meta-analysis. Pediatr Infect Dis J. 2022;41(8):e308-e316.
Gao Y, Mbandi SK, Mendelsohn SC, Joosten SA, Ottenhoff THM, Hatherill M, et al. Novel RNA biomarkers improve discrimination of children with tuberculosis disease from those with non-TB pneumonia after in vitro stimulation. Front Immunol. 2024;15:1456123.
https://doi.org/10.3389/fimmu.2024.1401647
He J, Bhatnagar A, Philippy S, Liang L, Wormser GP, Hu L, et al. Serum-Based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a Retrospective Cohort Study. J Clin Microbiol. 2021;59(2):e01949-20.
https://doi.org/10.1128/jcm.01756-20
Pace D, Lodi L, Chiappini E, Galli L. Extrapulmonary and Drug-Resistant Childhood Tuberculosis. Children (Basel). 2023;10(12):1899.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
